Case Control Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 14, 2021; 27(2): 162-175
Published online Jan 14, 2021. doi: 10.3748/wjg.v27.i2.162
Figure 5
Figure 5 Measurement of serum 10-7G values and correlation between 10-7G values and C-reactive protein in healthy volunteers who underwent a medical examination. A: The 10-7G value of healthy volunteers (HVs) who had elevated C-reactive protein (CRP) levels (> 0.3 mg/dL) diagnosed during routine medical examination (CRP-high HVs); B: Coefficient of correlation between the 10-7G value and CRP level in CRP-high HVs; C: 10-7G values of inflammatory bowel disease (IBD) patients with normal CRP level (≤ 0.3 mg/dL) (CRP-normal IBD) or high CRP level (> 0.3 mg/dL) (CRP-high IBD); D: Coefficient of correlation between the 10-7G value and CRP level in IBD patients. HV: Healthy volunteer; CRP: C-reactive protein; IBD: Inflammatory bowel disease; NS: Not significant.

  • Citation: Motooka K, Morishita K, Ito N, Shinzaki S, Tashiro T, Nojima S, Shimizu K, Date M, Sakata N, Yamada M, Takamatsu S, Kamada Y, Iijima H, Mizushima T, Morii E, Takehara T, Miyoshi E. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis. World J Gastroenterol 2021; 27(2): 162-175
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i2/162.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i2.162